Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Bria

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 20, 2004
Zoledronic acid-associated thrombotic thrombocytopenic purpuraG Ferretti, M C Petti, P Carlini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2006
Non-small cell lung cancer: early stagesE Bria, A Ceribelli, M G Trovò, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 2005
Is cardiac troponin T serum level an accurate surrogate for acute doxorubicin-related myocardial injury?G Ferretti, M Mandalà, E Bria, et al.
Chemical Communications (Cambridge, England)|August 2, 2007
Synthesis and structural characterization of cross-linked histidine-phenol Cu(ii) complexes as cytochrome c oxidase active site modelsKimberly N White, Indranil Sen, Istvan Szundi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 18, 2011
Outcome of advanced NSCLC patients harboring sensitizing EGFR mutations randomized to EGFR tyrosine kinase inhibitors or chemotherapy as first-line treatment: a meta-analysisE Bria, M Milella, F Cuppone, et al.
Gut|May 13, 2005
Is stool DNA multitarget testing an unreliable strategy for colorectal cancer screening?G Ferretti, E Bria, P Carlini, et al.
Expert Opinion on Pharmacotherapy|September 30, 2016
Current and developing therapies for the treatment of non-small cell lung cancer with ALK abnormalities: update and perspectives for clinical practiceM Caccese, R Ferrara, S Pilotto, et al.
Journal of Thrombosis and Haemostasis : JTH|June 18, 2026
Time-to-Start of Anticoagulant Therapy and Mortality in Pulmonary EmbolismKelsey E Bria, Brian F Gage, Alejandra Gutierrez, et al.
Critical Care Medicine|April 23, 2026
Effects of Early Versus Delayed Mechanical Thrombectomy on Outcomes in Intermediate-Risk Acute Pulmonary EmbolismCaleb J Chiang, Kelsey E Bria, Pavlina Chrysafi, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 19, 2007
Nuclear and cytoplasmic cellular distribution of survivin as survival predictor in resected non-small-cell lung cancerE Bria, P Visca, F Novelli, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 20, 2004
Zoledronic acid-associated thrombotic thrombocytopenic purpuraG Ferretti, M C Petti, P Carlini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2006
Non-small cell lung cancer: early stagesE Bria, A Ceribelli, M G Trovò, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 2005
Is cardiac troponin T serum level an accurate surrogate for acute doxorubicin-related myocardial injury?G Ferretti, M Mandalà, E Bria, et al.
Chemical Communications (Cambridge, England)|August 2, 2007
Synthesis and structural characterization of cross-linked histidine-phenol Cu(ii) complexes as cytochrome c oxidase active site modelsKimberly N White, Indranil Sen, Istvan Szundi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 18, 2011
Outcome of advanced NSCLC patients harboring sensitizing EGFR mutations randomized to EGFR tyrosine kinase inhibitors or chemotherapy as first-line treatment: a meta-analysisE Bria, M Milella, F Cuppone, et al.
Gut|May 13, 2005
Is stool DNA multitarget testing an unreliable strategy for colorectal cancer screening?G Ferretti, E Bria, P Carlini, et al.
Expert Opinion on Pharmacotherapy|September 30, 2016
Current and developing therapies for the treatment of non-small cell lung cancer with ALK abnormalities: update and perspectives for clinical practiceM Caccese, R Ferrara, S Pilotto, et al.
Journal of Thrombosis and Haemostasis : JTH|June 18, 2026
Time-to-Start of Anticoagulant Therapy and Mortality in Pulmonary EmbolismKelsey E Bria, Brian F Gage, Alejandra Gutierrez, et al.
Critical Care Medicine|April 23, 2026
Effects of Early Versus Delayed Mechanical Thrombectomy on Outcomes in Intermediate-Risk Acute Pulmonary EmbolismCaleb J Chiang, Kelsey E Bria, Pavlina Chrysafi, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 19, 2007
Nuclear and cytoplasmic cellular distribution of survivin as survival predictor in resected non-small-cell lung cancerE Bria, P Visca, F Novelli, et al.
Pageof 6